FDA — authorised 12 February 2020
- Marketing authorisation holder: BRAINTREE LABS
- Status: approved
FDA authorised Pizensy on 12 February 2020
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 12 February 2020.
BRAINTREE LABS holds the US marketing authorisation.